Key facts
- Peripear’s last known valuation is $3.9M (Jun 2025).
- It has raised $190K; the latest was Seed Round ($190K) in Jun 2025.
- Notable investors include Zinc, Accelerating FemTech, Deuce Capital, ImpactU (United Kingdom), Lavender Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Peripear
- ·The full record, as it builds
Funding rounds
No funding rounds for Peripear are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Peripear
Developer of wearable technology designed to prevent injuries, ease pain, and make birth safer and smoother for everyone. The company's birth-oriented effective device, based on existing clinical evidence, allows customers an injury-free and harmless childbirth process, enabling mothers a painless recovery.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2024
- Employees
- 7
- Website
- peri-pear.com/
- Ownership
- Privately Held (backing)
Peripear doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Peripear shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Peripear in its N-PORT filings yet. We sweep new filings monthly.